Home > Our Doctors > Find a Doctor

Select Physicians to compare
Photo of Douglas Esberg

Douglas B Esberg , MD

Request an Appointment

Need help deciding?
Contact 1.866.CALL.MLH or
484.580.1000 for assistance.

Medical Group:

Lankenau Heart Group

Primary Office:

Lankenau Heart Pavilion, Mezzanine Level
100 East Lancaster Avenue
Wynnewood, PA  19096

Office Phone: 484.476.1000
Main Line HealthCare Physician
Specialties Accepting New Patients
Electrophysiology
  Board Certified in 2001
Yes
Cardiovascular Disease
  Board Certified in 2000
Yes
Internal Medicine
  Board Certified in 1997
No
Age: 46     Gender: M
Years in practice: 13

Medical School:
New York Medical College

Internship:
Columbia Presbyterian Medical

Residency:
Columbia Presbyterian Medical

Fellowship:
Thomas Jefferson University Hospital

Primary Affiliation:  Lankenau Medical Center

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Lankenau Heart Group   (view other physicians at this practice)

Office Information

Location:
Lankenau Heart Pavilion, Mezzanine Level
100 East Lancaster Avenue
Wynnewood, PA  19096

TEL: 484.476.1000 FAX: 484.476.9000
View Map | Get Directions

Access Information:
Public Transportation, Handicap Access

hours icon Hours: Weekdays
 
Location:
7114 Ridge Avenue
Philadelphia, PA  19128

TEL: 484.476.1000 FAX: 484.476.9000
View Map | Get Directions

Access Information:
Public Transportation, Handicap Access

hours icon Hours: Weekdays
 
Lankenau Heart Group
100 East Lancaster Avenue
Wynnewood, PA  19096

TEL: 484.476.1000 FAX: 484.476.9000

View Map | Get Directions

Access Information:
Public Transportation, Handicap Access

Hours:Weekdays

Lankenau Heart Group Philadelphia, PA  19128

TEL: 484.476.1000 FAX: 484.476.9000

View Map | Get Directions

Access Information:
Public Transportation, Handicap Access

Hours:Weekdays



Titles

Academic Titles:
Assistant Clinical Professor of Medicine - Jefferson Medical College

Clinical/Dept Titles:

Director, Clinical Cardiac Electrophysiology Fellowship Program - Lankenau Medical Center

Recent Clinical Studies Published

Clinical Study Participation

  • Guidant siteline lead study
    • Sub-investigator
  • LV Capture Management Clinical Trial (Medtronic)
    • Site Principle Investigator
  • AWARE (St. Jude)
    • Site Principle Investigator
  • PEGASUS (Guidant)
    • Site Principle Investigator
  • Block HF (Medtronic)
    • Sub-investigator
  • Chili VT Study (Boston Scientific)
    • Sub-investigator
  • DIARY (Guidant)
    • Sub-investigator
  • InSync III Marquis Study (Medtronic)
    • Sub-investigator
  • Evaluation of Radiofrequency Ablation of Typical (Type I) Atrial Flutter Using the Navi-Star™ DS (8mm tip) Catheter with the Stockert 70™ RF Generator. (Boston Scientific)
    • Site Principle Investigator
  • Freezor™ Trial Of Supraventricular Tachycardia (FROSTY). (Cryocath)
    Evaluation of the 7Fr Freezor Focal Ablation Catheter to treat AVRT, AVNRT and AF
    • Sub-investigator
  • Synergistic Effects of Risk Factors for Sudden Cardiac Death (SERF). (Guidant)
    • Site Principle Investigator
  • Silent Atrial Fibrillation Detection with Stored Electrograms (SAFE). (Guidant)
    • Sub-investigator
  • Atrial High Rate Episodes in Pacemaker Patients (AHIRATE). (Medtronic)
    • Site Principle Investigator
  • AutoCapture Capabilities with ICD Leads. (St. Jude)
    • Sub-investigator
  • Marquis VR Clinical Study. (Medtronic)
    • Sub-investigator
  • A Six-Month Multi-center, Double-blind, Placebo-controlled, Parallel-group design Clinical Study to Assess The Efficacy and Safety of 125 mg Daily Oral Dose of Azimilide Dihydrochloride for the Treatment of Atrial Fibrillation in Patients Who Require Electrical Cardioversion, with an Open-label Follow-up Phase to Assess the Long-term Efficacy and Safety of 125 mg Daily Oral Dose of Azimilide Dihydrochloride.
    • Sub-investigator
  • Placebo-controlled Dose-finding Safety and Tolerability Study of Dofetilide in Patients with an Implantable Cardioverter Defibrillator (ICD).
    • Sub-investigator

Publications

Olshansky B, Day JD, Moore S, Gering L, Rosenbaum M, McGuire M, Brown S and Lerew D. Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study. Circulation 2007; 115(1).

Natarajan S, Henthorn R, Burroughs J, Esberg D, Zweibel S, Ross T, Kroll M and Gianola D. "Tuned" Defibrillation Waveforms Outperform 50/50% Tilt Defibrillation Waveforms: A Randomized Multi-Center Study. PACE 2007; vol 30 (Supplement 1): S139-S142.

Esberg D, Kowey P. Does “Anti-lipid” Also Mean "Anti-arrhythmic" [Editorial]. J of Cardiac Failure 2005; 11(9): 693-694.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure (COMPANION), NEJM 2004; 350(21): 2140-50.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
JAMA. 2002 Dec 25;288(24):3115-23.

Esberg D, Greenspon AJ. Avoiding Complications of Catheter Ablation: A Review of the Current State of the Art [Review]. J Invasive Cardiol 2001; 13(4): 323-327.

Recent Honors, Awards, Citations

2013 - TOP DOC - Main Line Today Magazine

Fellowship in Cardiovascular Medicine
Thomas Jefferson University Hospital, Philadelphia, PA
7/97-6/00

Fellowship in Clinical Cardiac Electrophysiology
Thomas Jefferson University Hospital, Philadelphia, PA
7/00-6/01

Current Memberships and Activities

  • Fellow - American College of Cardiology
  • Fellow - Heart Rhythm Society

GENERAL

Specialties: Electrophysiology (Board Certified in 2001) - Accepting New Patients
Cardiovascular Disease (Board Certified in 2000) - Accepting New Patients
Internal Medicine (Board Certified in 1997) - Not Accepting New Patients
Age: 46     Gender: M
Years in practice: 13

Medical School:
New York Medical College

Internship:
Columbia Presbyterian Medical

Residency:
Columbia Presbyterian Medical

Fellowship:
Thomas Jefferson University Hospital

Primary Affiliation:  Lankenau Medical Center

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Titles

Academic Titles:
Assistant Clinical Professor of Medicine - Jefferson Medical College

Clinical/Dept Titles:

Director, Clinical Cardiac Electrophysiology Fellowship Program - Lankenau Medical Center


PRACTICE

Practice Name:
Lankenau Heart Group

appointment icon Locations:

Lankenau Heart Pavilion, Mezzanine Level
100 East Lancaster Avenue
Wynnewood, PA  19096
TEL: 484.476.1000 FAX: 484.476.9000
transportation icon Access Information:  Public Transportation,Handicap Access
hours icon Hours: Weekdays
7114 Ridge Avenue
Philadelphia, PA  19128
TEL: 484.476.1000 FAX: 484.476.9000
transportation icon Access Information:  Public Transportation,Handicap Access
hours icon Hours: Weekdays

PUBLICATIONS & CITATIONS

Recent Clinical Studies Published

Clinical Study Participation

  • Guidant siteline lead study
    • Sub-investigator
  • LV Capture Management Clinical Trial (Medtronic)
    • Site Principle Investigator
  • AWARE (St. Jude)
    • Site Principle Investigator
  • PEGASUS (Guidant)
    • Site Principle Investigator
  • Block HF (Medtronic)
    • Sub-investigator
  • Chili VT Study (Boston Scientific)
    • Sub-investigator
  • DIARY (Guidant)
    • Sub-investigator
  • InSync III Marquis Study (Medtronic)
    • Sub-investigator
  • Evaluation of Radiofrequency Ablation of Typical (Type I) Atrial Flutter Using the Navi-Star™ DS (8mm tip) Catheter with the Stockert 70™ RF Generator. (Boston Scientific)
    • Site Principle Investigator
  • Freezor™ Trial Of Supraventricular Tachycardia (FROSTY). (Cryocath)
    Evaluation of the 7Fr Freezor Focal Ablation Catheter to treat AVRT, AVNRT and AF
    • Sub-investigator
  • Synergistic Effects of Risk Factors for Sudden Cardiac Death (SERF). (Guidant)
    • Site Principle Investigator
  • Silent Atrial Fibrillation Detection with Stored Electrograms (SAFE). (Guidant)
    • Sub-investigator
  • Atrial High Rate Episodes in Pacemaker Patients (AHIRATE). (Medtronic)
    • Site Principle Investigator
  • AutoCapture Capabilities with ICD Leads. (St. Jude)
    • Sub-investigator
  • Marquis VR Clinical Study. (Medtronic)
    • Sub-investigator
  • A Six-Month Multi-center, Double-blind, Placebo-controlled, Parallel-group design Clinical Study to Assess The Efficacy and Safety of 125 mg Daily Oral Dose of Azimilide Dihydrochloride for the Treatment of Atrial Fibrillation in Patients Who Require Electrical Cardioversion, with an Open-label Follow-up Phase to Assess the Long-term Efficacy and Safety of 125 mg Daily Oral Dose of Azimilide Dihydrochloride.
    • Sub-investigator
  • Placebo-controlled Dose-finding Safety and Tolerability Study of Dofetilide in Patients with an Implantable Cardioverter Defibrillator (ICD).
    • Sub-investigator

Publications

Olshansky B, Day JD, Moore S, Gering L, Rosenbaum M, McGuire M, Brown S and Lerew D. Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study. Circulation 2007; 115(1).

Natarajan S, Henthorn R, Burroughs J, Esberg D, Zweibel S, Ross T, Kroll M and Gianola D. "Tuned" Defibrillation Waveforms Outperform 50/50% Tilt Defibrillation Waveforms: A Randomized Multi-Center Study. PACE 2007; vol 30 (Supplement 1): S139-S142.

Esberg D, Kowey P. Does “Anti-lipid” Also Mean "Anti-arrhythmic" [Editorial]. J of Cardiac Failure 2005; 11(9): 693-694.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure (COMPANION), NEJM 2004; 350(21): 2140-50.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
JAMA. 2002 Dec 25;288(24):3115-23.

Esberg D, Greenspon AJ. Avoiding Complications of Catheter Ablation: A Review of the Current State of the Art [Review]. J Invasive Cardiol 2001; 13(4): 323-327.

Recent Honors, Awards, Citations

2013 - TOP DOC - Main Line Today Magazine

Fellowship in Cardiovascular Medicine
Thomas Jefferson University Hospital, Philadelphia, PA
7/97-6/00

Fellowship in Clinical Cardiac Electrophysiology
Thomas Jefferson University Hospital, Philadelphia, PA
7/00-6/01

Current Memberships and Activities

  • Fellow - American College of Cardiology
  • Fellow - Heart Rhythm Society

Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.

Compare Physicians
  •  

Connect with MLH

New Appointments
1.866.CALL.MLH

 Well Ahead Newsletter


STAY CONNECTED

Copyright 2014 Main Line Health

Printed from: www.mainlinehealth.org/phy/Page.asp?PageID=PHY000421

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.